Standard Family Office’s Novo Nordisk NVO Stock Holding History

Standard Family Office’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-198	Closed	-$10K	–	309
2022 Q3	$10K	Buy	+198	New	+$10.6K	﹤0.01%	253
2021 Q1	–	Sell	-1,830	Closed	-$64K	–	652
2020 Q4	$64K	Buy	+1,830	New	+$63.3K	0.02%	243

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Standard Family Office's NVO Position: Q4 2022 in Review

Standard Family Office sold out of Novo Nordisk (NVO) in Q4 2022, closing a stake of 198 shares — an estimated $10K sold.

Standard Family Office first reported a position in NVO in Q4 2020 and held it in 2 quarters. The position peaked at $64K in Q4 2020. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

Standard Family Office reported no remaining Novo Nordisk position as of Q4 2022 after selling out during the quarter.
Standard Family Office sold 198 Novo Nordisk shares in Q4 2022, an estimated $10K.
Standard Family Office first reported a position in Novo Nordisk in Q4 2020 and held it in 2 quarters.
Standard Family Office's Novo Nordisk position peaked at $64K in Q4 2020.
1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.